Skip to content
AiONAiON

Disability-free survival

Primary endpoint of the ASPREE trial in healthy older people; aspirin did not prolong disability-free survival over 5 years.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.